Page last updated: 2024-09-05

dabigatran and Scleroderma, Systemic

dabigatran has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bogatkevich, GS; Ludwicka-Bradley, A; Silver, RM	1

Other Studies

1 other study(ies) available for dabigatran and Scleroderma, Systemic

Article	Year
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis and rheumatism, 2009, Volume: 60, Issue:11 Topics: Actins; Anticoagulants; Benzimidazoles; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Dabigatran; Dose-Response Relationship, Drug; Fibroblasts; Humans; Lung; Pulmonary Fibrosis; Pyridines; Receptor, PAR-1; Scleroderma, Systemic; Signal Transduction; Thrombin	2009

Article

Year

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.

Arthritis and rheumatism, 2009, Volume: 60, Issue:11

Topics: Actins; Anticoagulants; Benzimidazoles; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Dabigatran; Dose-Response Relationship, Drug; Fibroblasts; Humans; Lung; Pulmonary Fibrosis; Pyridines; Receptor, PAR-1; Scleroderma, Systemic; Signal Transduction; Thrombin

2009